Wishard morphs into Eskenazi Hospital
After suffering for years with decrepit heating and ventilating systems, Wishard, the busiest hospital in the state, finally got a new home. And a new name.
After suffering for years with decrepit heating and ventilating systems, Wishard, the busiest hospital in the state, finally got a new home. And a new name.
The deadline to enroll in plans that begin Jan. 1 now is midnight Tuesday for most of the U.S. On Monday, healthcare.gov fielded nearly 50,000 simultaneous visitors, triggering a queuing system.
Laura Noblitt is a Zionsville-based occupational therapist with 25 years of experience in geriatric rehabilitation. She has spent half a decade riding shotgun with elderly drivers in central Indiana, determining whether it’s safe for them to stay behind the wheel.
Eli Lilly and Co., Pfizer Inc., Sanofi and other large drugmakers will keep paying doctors to give talks about their products, leaving GlaxoSmithKline Plc alone for now in its decision to halt such compensation.
Consumers who enroll in health plans through the new U.S. exchanges will get 10 extra days to pay their first premiums and still gain coverage effective Jan. 1, an insurance company trade group said Wednesday.
Fifteen years after Pfizer Inc.’s Viagra changed the sexual equation for older men, the blockbuster impotence drug is set to become available in a less expensive generic form as early as 2017.
Even though St. Louis-based Ascension Health cut nearly 900 jobs this year from its Indianapolis-based hospital subsidiary, St. Vincent Health, it wants to add 549 more to its service center here by 2016.
There's more disappointing news about multivitamins: Two major studies found popping the pills didn't protect aging men's brains or help heart attack survivors.
The facility in Columbus would be the first of its kind for the company. Should the concept prove successful, Cummins will consider similar arrangements in other areas with Cummins plants, said Dr. Dexter Shurney, chief medical officer for Cummins.
Eskenazi Health leadership’s desire to connect the diversity of its hospital’s population through a healing park drew in a landscape architect firm that is not only one of the top in the country, but also one of the hottest architecture firms in the world.
Tom Fischer, the chief financial and chief operating officer of Community Health Network, departed suddenly this month. Sources with knowledge of the situation described Fischer’s exit as a firing. But a Community spokeswoman said Fischer resigned in a private meeting with Community CEO Bryan Mills.
Since 1998, there have been more than 100 attempts to develop an Alzheimer’s treatment, and all have failed. Such a product may generate as much as $5 billion annually for Merck, according to analysts
Cymbalta is Eli Lilly and Co. Inc.'s best-selling drug and posted 2012 sales of $4.7 billion, making it the fifth-highest selling medication in the world. The drug's patent expired Wednesday.
Indiana Gov. Mike Pence is scheduling a meeting with U.S. Health and Human Services Secretary Kathleen Sebelius about the state’s request to use its own health care plan in place of a traditional Medicaid expansion.
Enrollment in November was about four times faster than in October, but it will need to be about 12 times faster through the end of March to meet federal projections.
The Family and Social Services Administration announced Tuesday it is extending its Healthy Indiana Plan to participants who earn between 100 percent and 200 percent of the federal poverty level.
Eskenazi admitted its first patients and the hospital it's replacing, Wishard Memorial, discharged its last Saturday as part of the transition between the two hospitals.
The new climate is a seismic change for many who got into nursing because for generations it had been a recession-proof career.
The new $754 million hospital is scheduled to begin accepting patients at 7 a.m. Saturday, which is one minute after Wishard Hospital will stop accepting patients.
Edivoxetine, a derivative of Lilly's Strattera drug for attention deficit disorder, was in the final of three stages of testing usually required for marketing approval by U.S. regulators.